Merck Postdoctoral Research Fellows Program

Merck Postdoctoral Research Fellows Program is sponsored by Merck. This opportunity supports mission-aligned projects and measurable outcomes.

Postdoctoral research fellows program - Merck. com Postdoctoral research fellows program Accelerate your career by pursuing groundbreaking research with world-class scientists. Hands-on experience for the next generation of researchers Our Postdoctoral Research Fellows Program aims to be a best-in-industry experience for PhD graduates, providing academic focus in a large pharmaceutical environment.

With Merck’s resources, reach and expertise at their fingertips, our postdoctoral fellows work under the mentorship of our dedicated researchers and alongside a diverse team of scientists striving to transform world-class science into life-changing medicines and vaccines.

Postdoctoral fellows at Merck gain: Obtain unmatched hands-on experience in drug discovery and development Generate scientific results and publish in high-impact journals Build a strong foundation in the scientific community through meaningful connections with experts and peers Gain unparalleled experience to pursue preferred career opportunities in research and development Our program by the numbers By collaborating closely with our scientists to apply the latest cutting-edge research technologies, our postdoctoral fellows are primed to excel in an institution dedicated to breakthrough innovation in research and development.

Postdocs working across our R&D laboratories Our scientists and postdocs are encouraged to be active members of the scientific community and have published papers in numerous peer-reviewed, thought-leading publications. Every day our scientists, from all backgrounds and disciplines, work together to use the power of leading-edge science to save and improve lives.

Our postdoctoral fellows in action Postdoc POV: In the labs with Matthew Growing leadership as a postdoctoral mentor A day in the life of a postdoctoral fellow Establishing impact within Merck’s postdoctoral program Apply now: Postdoctoral program Explore how your ideas can grow with mentorship from leading scientific experts through our established postdoctoral research fellow program.

Check out our R&D stories Harnessing innovative technology in drug discovery Merck scientists explain how new technologies can accelerate the drug discovery process as we use the power of leading-edge science to save and improve lives Podcast: Why neuroscience is the ‘final frontier’ Listen as specialists from Merck discuss what they’re most excited about in researching potential treatments for neurologic disorders Where our science happens Our research and development starts with the capabilities and expertise at our facilities, but we're open to collaboration anywhere the science leads us.

Meet our research leaders who are dedicated to pushing scientific boundaries. Our teams of scientists bring together diverse expertise and background, combined with cutting-edge technologies, to help discover the next scientific breakthrough for patients. Forward-Looking Statement of Merck & Co.

, Inc., Rahway, N. J. , USA This website of Merck & Co.

, Inc., Rahway, N. J. , USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.

These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful.

If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2025 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site ( www. sec. gov ).

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.